Harvard Bioscience Inc
SWB:HBI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Harvard Bioscience Inc
SWB:HBI
|
US |
|
M
|
Microsoft Corp
HKEX:4338
|
US |
|
C
|
Costco Wholesale Corp
DUS:CTO
|
US |
|
Kurabo Industries Ltd
TSE:3106
|
JP |
|
Nextera Energy Inc
NYSE:NEE
|
US |
|
Adecco Group AG
OTC:AHEXY
|
CH |
|
NetEase Inc
LSE:0K6G
|
CN |
|
A-Living Smart City Services Co Ltd
F:1V0
|
CN |
|
Systemair AB
STO:SYSR
|
SE |
|
N
|
NetEase Inc
SGX:K3MD
|
CN |
|
Adidas AG
XETRA:ADS
|
DE |
|
Ringkjoebing Landbobank A/S
CSE:RILBA
|
DK |
|
NetEase Inc
NASDAQ:NTES
|
CN |
|
T
|
Tetra Technologies Inc
F:TGI
|
US |
|
Northeast Community Bancorp Inc
F:JY4
|
US |
Wall St Price Targets
HBI Price Targets Summary
Harvard Bioscience Inc
According to Wall Street analysts, the average 1-year price target for
HBI is 4.24 EUR with a low forecast of 4.2 EUR and a high forecast of 4.36 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HBI's stock price target?
Price Target
4.24
EUR
According to Wall Street analysts, the average 1-year price target for
HBI is 4.24 EUR with a low forecast of 4.2 EUR and a high forecast of 4.36 EUR.
What is the Revenue forecast for Harvard Bioscience Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 2 years is 5%.
What is the Gross Profit forecast for Harvard Bioscience Inc?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 2 years is 8%.